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Background: Less sleep time and snoring have been associated with cardiovascular disease (CVD) risk in Western
populations; however, few studies have evaluated the different aspects of sleep duration and snoring frequency in
relation to CVD, and this association has not been examined in China. The present study aimed to address the
relation between sleep duration, snoring frequency and risk of acute myocardial infarction (AMI) in China
population.
Methods: We conducted a hospital-based case–control study. Cases were first AMI (n = 2909). Controls were
matched to cases on age and sex. 2947 controls who did not report previous angina or physical disability
completed a questionnaire on sleep duration and snoring frequency. We used logistic regression to control for
other risk factors.
Results: We observed an inverse association between serious snoring frequency and AMI risk. After adjustment for
all the risk factors, and the OR for everyday group and 3–5 times per week group was 1.45 (95% CI: 1.01 to 1.91)
and 1.93 (95% CI: 1.52-2.46) compared to no snoring group. The OR for serious level group and moderate group
was 1.77 (95% CI: 1.29 to 2.43) and 1.37 (95% CI: 1.10 to 1.69) compared to no snoring group. People having serious
snoring increased 77% risk of AMI. 15.2% people in control group have ≤ 6 hours sleeping, compared with 17.4% in
AMI group.
Conclusions: Snoring frequency, including as much as everyday and 3–5 times per week, was positively associated
with AMI risk and less sleep duration was associated with risk of AMI. Less sleep time could increase AMI risk in
China population.
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Cardiovascular disease (CVD) is the leading cause of
death and disability-adjusted life-years world wide, with
increasing incidence and prevalence in low- and middle-
income countries. By 2020, more than 80% of global
CVD will be in these countries, with the largest burden
occurring in the two largest countries, China and India,
as they rapidly urbanise [1].* Correspondence: liwei@mrbc-nccd.com
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unless otherwise stated.Sleep duration has been associated with CVD, stroke,
diabetes, hypertension, and all-cause mortality [2-13]. A
recent meta-analysis documented that compared with
7 hours of sleep, shorter duration of sleep was associated
with up to a 2-fold increased risk for CVD-related mor-
tality [2]. For both men and women, lack of sleep has
been associated with increased risk of cardiovascular
events [5,6]. Amagai et al. 3 showed that sleeping less
than 6 hours per night, when compared with sleeping 7
to 7.9 hours per night, was associated with CVD risk of
2.14 for men and 1.46 for women. Understanding the re-
lation between lack of sleep and adverse health effects is
important because over the last 30 years, diminished. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the population in 1975 to 9.3% in 2006 [14]. Potential
mechanisms for the relation between inadequate sleep
and increased cardiovascular risk include up-regulation
of appetite and decreased energy expenditure, leading to
obesity and its metabolic consequences, and alterations
in glucose metabolism [15,16].
Associations of snoring with cardiovascular disease was
examined cross-sectionally [17,18] in clinical and large-
scale epidemiologic studies, most of which clearly showed
an independent positive association, even after adjustment
for potential confounding factors such as age, sex, and
body mass index (BMI) [19]. This causal relationship has
also been observed in studies of Western populations. As
compared with non-snorers, the relative risk of developing
cardiovascular disease among habitual snoring American
women was 30% higher in the Nurses’ Health Study [20],
and the risk among habitual and frequent snoring Finish
men was 2.1-fold higher [21]. However, evidence from
Asian populations is still very limited, and these results
from Western studies cannot simply be extrapolated to
Asian populations.
The purpose of this study was to assess the association
between sleep habits, defined as sleep duration and snor-
ing, and measured risk factors for CVD in China popula-
tion, including both traditional and psychosocial risk
factors. An additional aim of the research was to evalu-
ate the potential mechanisms related to sleep habits and




INTERHEART China study is a case–control study. In
the study, 2909 patients with incident cases of acute
myocardial infarction (AMI) and 2947 control subjects
free of heart disease from 27 regions in China were en-
rolled between February 1999 and March 2003.
To identify first cases of acute myocardial infarc-
tion, all patients (irrespective of age) admitted to the
coronary care unit or equivalent cardiology ward, pre-
senting within 24 h of symptom onset, were screened.
Cases were eligible if they had characteristic symp-
toms plus electrocardiogram changes indicative of a
new myocardial infarction. At least one age-(±5 years)
and sex-matched control (without a history of CVD)
was recruited for each case from non-cardiac wards
or unrelated visitors of cardiac patients, or patients at
the same centers with illnesses not obviously related
to CVD or its risk factors. At entry to the study, in-
formed consent was obtained from each subject. This
study was approved by appropriate regulatory and ethics
councils in all participating centers. A structured and
pre-tested questionnaire was administered and physicalexaminations were undertaken in the same manner
among cases and controls [22-24].Ethical approval and informed consent
Subjects willing to participate are subsequently sent
written information on the study procedures along with
an informed consent form. Only participants providing
written informed consent are enrolled. Ethical approval
was obtained by the Medical Ethical Committee of
Beijing Fu Wai Hospital.Procedures
Trained personnel administered the structured question-
naires and physical examinations in a standardized manner.
Information about demographic factors, family income and
education, lifestyle, personal and family history of CVD and
risk factors, psychosocial factors, physical activities, and
smoking history, alcohol use were obtained with the use of
standardized INTERHEART questionnaires. Personal and
family patterns of cardiovascular disease (CVD) and risk
factors were recorded, and histories of hypertension and
diabetes were self-reported. Three categories of educa-
tional level were created: none or 1–8 years, 9–12 years,
trade school or college or university. Family income de-
fined as three groups. Three categories were lower group
(≤ 6000 yuan/year), middle group (6000–10000 yuan/
year), and higher group (≥ 10000 yuan/year) according to
the level of income. Questions were included about
psychosocial conditions to identify depressive mood
and psychological stress. General psychological stress
was defined as experiencing stress at work or at home
and was also assessed in the four categories. Subjects were
asked whether they had suffered from some Stressful life
events in the previous year, including marital separation/
divorce, loss of job/retirement, loss of crop/business fail-
ure, violence, major intra-family conflict, major personal
injury or illness, death/major illness of a close family mem-
ber, death of a spouse and other major stress. Blood pres-
sure, height, weight, waist and hip circumferences were
measured. Body mass index (BMI) was defined as weight
(kg) divided by squared height (m2).
During the INTERHEART examination, a self-administered
sleep history questionnaire was obtained. Among the
questions were a) “Have you ever snored (now or at any
time in the past)?”; if yes, “How frequent and loudly
do you snore?”; b) “How long your night’s sleep?” Partic-
ipants were provided 4 responses to each question: ≤ 6,
6–8, > 8, don’t know; and c) “Do you have the habit
of napping?”; if yes, “How long do you nap every-
day?”. Among the INTERHEART participants, who
did not report “don’t know” to either the sleep or snor-
ing questions and were therefore excluded from this
analysis.
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Clinical data of continuous variables expressed as mean
(SD) and differences were assessed by rank test. Categor-
ical variables were represented as percentage and were
tested by Pearson chi-squared analysis.
The association between sleep, snoring frequency and
AMI was assessed in several different ways. In models
which adjusted for age, sex and area, we investigated the
effect on each variable on the risk of AMI. Subsequently,
multivariable logistic regression models were built where,
after adjustment for age and sex, we separately introduced
(1) age, sex, BMI, hypertension, diabetes, stroke and family
history of MI. (2) age, sex, area, WHR, BMI, smoking,
drinking, physical activity, consumption of vegetables and
fruits. (3) age, sex, area, educational status, householdTable 1 Characteristics of participants
Characteristics AMI cases, N = 2909
Male sex (%) 2027 (69.7)
Mean Age (SD), year 62.1 (11.7)
BMI, n (%)
≤ 24 1173 (40.3)
24-28 1358 (46.7)
> 28 378 (13.0)
WHR, mean (SD), cm/cm 0.88 (0.08)
Hypertension (%) 1145 (39.5)
Diabetes (%) 360 (12.4)
Stroke (%) 317 (10.9)
Family history of MI, n (%) 102 (3.5)
Smoking, n (%) 1694 (58.2)
Alcohol, n (%) 463 (15.9)
Physical activity, n (%) 128 (14.8)
Educational status, n (%)
Trade school/college/university 553 (19.1)
9-12 years 799 (27.5)





Single or divorced, n (%) 366 (12.6)
General stress, n (%)
Permanent 1083 (37.4)
Several periods 1311 (45.3)
Never experienced 500 (17.3)
Depressed, n (%) 559 (19.6)
Consumption of vegetables (times/week) 7.8 (5.5)
Consumption of fruits (times/week) 4.0 (3.7)
N, number; p-value, significance of difference between group means and frequencyincome, marital status, stress and depression. Age, BMI,
and whr levels were approximate a normal distribution.
P < 0.05 was used to indicate statistically significant dif-
ferences. Significance was assessed by a Wald test and by
a likelihood-ratio test.
During this process, we explored the interaction be-
tween snoring frequency and other risk factors. The Wald
chi-square test was used to test the interaction.
All statistical tests were two-sided. Statistical analyses
and graphics were produced with the SAS software ver-
sion 9.1.3 and Excel.
Results
In the INTERHEART China study, cases and controls,
matched by age and gender, were enrolled between FebruaryControls, N = 2947 χ2/Z P-value
2048 (69.5) 0.02 0.8771





0.88 (0.08) 2.16 0.2011
656 (22.26) 203.68 0.0001
87 (3.0) 185.54 0.0001
102 (3.5) 122.76 0.0001
54 (1.8) 15.93 0.0001
1186 (40.2) 189.54 0.0001
429 (14.6) 2.09 0.1479














273 (9.3) 122.88 0.0001
7.9 (5.4) −1.10 0.2705
4.8 (3.7) −9.29 0.0001
determined by rank-test and chi-square test.
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http://www.biomedcentral.com/1471-2458/14/5311999 and March 2003 from 27 regions in China. Charac-
teristics of Participants were shown in Table 1. History of
hypertension, diabetes and stroke, smoking, education sta-
tus, income, general stress, dietary frequency and both
higher WHR and BMI levels were significant determinants
of AMI in this population.
Age-, sex- and area-adjusted and multivariable adjusted
Odds ratio (OR) for AMI risk factors are presented in
Table 2. After adjustment for age and sex, the OR associ-
ated with nap after lunch, compared with no nap was 1.06
(95% CI: 0.96 to 1.18). The model adjusted for all vari-
ables, the ORs were 0.94 (95% CI: 0.84 to 1.07).
After adjustment for age and sex, the OR associated
with snoring everyday, compared with no snoring was
2.06 (95% CI: 1.61 to 2.63), for 3–5 times per week
group was 2.50 (95% CI: 2.02 to 3.11), for 1–3 times per
week group was 1.40 (95% CI: 1.21 to 1.62), and for 0–1
time per week group was 1.06 (95% CI: 0.91 to 1.24).
After adjustment for age, sex, area, whr, bmi, smoking,
drinking, physical activity, consumption of vegetables
and fruits, these estimates were slightly decreased (OR:
1.80, 95% CI: 1.39 to 2.33 for everyday group; OR: 2.20,
95% CI: 1.75 to 2.77 for 3–5 times per week group; OR:
1.29, 95% CI: 1.11 to 1.50 for 3–5 1–3 times per week;
OR: 0.94, 95% CI: 0.80 to 1.10 for 0–1 time per week
group). In the final model, adjusted for all the risk fac-
tors, and the OR for everyday group and 3–5 times per
week group was 1.45 (95% CI: 1.01 to 1.91) and 1.93
(95% CI: 1.52-2.46) compared to no snoring group.Table 2 Odds Ratios (95% confidence intervals) for Acute My
different levels of adjustments
Sleep and snoring Case (%) Control (%) Odds ratio
(95% CI)*
Nap after lunch
No 1384 (47.8) 1488 (50.5) 1.00
Yes 1510 (52.2) 1458 (49.5) 1.06 (0.96-1.18)
Snoring frequency
No snoring 546 (19.2) 725 (25.0) 1.00
0-1 time per week 635 (22.4) 796 (27.4) 1.06 (0.91-1.24)
1-3 times per week 1115 (39.3) 1069 (36.8) 1.40 (1.21-1.62)
> 3 times per week 542 (19.1) 313 (10.8) 2.31 (1.93-2.76)
Snoring severity
No snoring 532 (19.4) 732 (26.1) 1.00
Mild 1647 (59.9) 1685 (60.1) 1.35 (1.18-1.54)
Moderate 404 (14.7) 298 (10.6) 1.87 (1.55-2.26)
Serious 166 (6.0) 87 (3.1) 2.70 (2.03-3.59)
*Model adjusted for age, sex and area.
†Model adjusted for age, sex, area, hypertension, diabetes, stroke and family history
‡Model adjusted for age, sex, area, whr, bmi, smoking, drinking, physical activity, co
§Model adjusted for age, sex, area, educational status, household income, marital st
||Model adjusted for all the risk factors.In age-, sex- and area-adjusted analysis of snoring se-
verity (Table 2), people in the highest level (serious snor-
ing) had an OR of 2.70 (95% CI: 2.03 to 3.59; P value =
0.0001) compared with those in the lowest level (no
snoring). The association remained similar in multivari-
ate analysis. After adjustment for age, sex, area, educa-
tional status, household income, marital status, stress
and depression, OR associated with serious level group
was 2.65, compared with no snoring group. After adjust-
ment for age, sex, area, whr, bmi, smoking, drinking,
physical activity, consumption of vegetables and fruits,
with serious level group having an 20% decreased risk
compared with the no snoring group (OR = 2.18; 95%
CI: 1.62 to 2.95; P value = 0.0001). In final analysis ad-
justed for all the risk factors, the OR for serious level
group and moderate group was 1.77 (95% CI: 1.29 to
2.43) and 1.37 (95% CI: 1.10 to 1.69) compared to no
snoring group. People having serious snoring increased
77% risk of AMI.
The association of time of sleep and AMI are presented
in Table 3. 67.4% people in control group have 6–8 hours
sleeping, compared with 62.2% in AMI group (P-value,
0.0002). 15.2% people in control group have ≤ 6 hours
sleeping, compared with 17.4% in AMI group.
Age-, sex- and area-adjusted and multivariable adjusted
Odds ratio (OR) for snoring associated factors were pre-
sented in Table 4. After adjustment of all other variables,
BMI, hypertension, smoking, and general stress were asso-









1.00 1.00 1.00 1.00
1.00 (0.89-1.11) 1.05 (0.94-1.17) 1.00 (0.89-1.11) 0.94 (0.84-1.07)
1.00 1.00 1.00 1.00
1.08 (0.92-1.26) 0.94 (0.80-1.10) 1.06 (0.90-1.24) 0.94 (0.80-1.12)
1.33 (1.15-1.55) 1.29 (1.11-1.50) 1.37 (1.18-1.60) 1.20 (1.02-1.42)
1.92 (1.59-2.31) 2.03 (1.67-2.46) 2.17 (1.80-2.62) 1.72 (1.40-2.11)
1.00 1.00 1.00 1.00
1.32 (1.14-1.51) 1.22 (1.06-1.41) 1.33 (1.16-1.53) 1.16 (1.00-1.35)
1.60 (1.32-1.95) 1.66 (1.36-2.03) 1.77 (1.45-2.15) 1.37 (1.10-1.69)
2.08 (1.55-2.80) 2.18 (1.62-2.95) 2.65 (1.98-3.55) 1.77 (1.29-2.43)
of MI.
nsumption of vegetables and fruits.
atus, stress and depression.
Table 3 Sleep duration difference between Acute
Myocardial Infarction (AMI) participants and controls
Nap and sleep duration AMI cases Controls χ2 P-value
Nap duration (minutes) N = 1509 N = 1455 25.42 0.0001
≤ 30 384 (25.5) 489 (33.6)
30-60 791 (52.4) 704 (48.4)
> 60 334 (22.1) 262 (18.0)
Sleep duration (hours) N = 2873 N = 2918 17.09 0.0002
≤ 6 499 (17.4) 444 (15.2)
6-8 1787 (62.2) 1966 (67.4)
> 8 587 (20.4) 508 (17.4)
N, number; p-value, significance of difference between group frequency
determined by chi-square test.
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quency and related factors of AMI in the INTERHEART
China study. The interaction between levels of snoring
frequency and permanent stress was significant (P value
for interaction, 0.0155).
Figure 1 showed the association of snoring frequency
with risk for AMI in men versus women. In models
adjusted for all the risk factors, OR associated with
snoring frequency (3–5 times per week group, com-
pared to no snoring group), was 2.26 (95% CI: 1.30 toTable 4 Associations between Snoring and Acute Myocardial
AMI related factors
P value*





Hypertension (Yes vs No) 0.0001
Diabetes (Yes vs No) 0.9045
Stroke (Yes vs No) 0.0332
family history of MI (Yes vs No) 0.8834
Smoking (Yes vs No) 0.0001
Alcohol (Yes vs No) 0.0002
Physical activity (Yes vs No) 0.6928





Depressed (Yes vs No) 0.2133
*Calculated by Chi-squire test.
*Univariate association analysis by logistic regression.
†Model adjusted for all the risk factors.3.92) in women, 1.90 (95% CI: 1.44 to 2.50) in men,
(p value for heterogeneity, 0.1059). The effect of snor-
ing was stronger in younger population; the OR asso-
ciated with snoring frequency (everyday group, compared
to no snoring group), was 1.88 (95% CI: 1.25 to 2.83) in
younger, 1.18 (95% CI: 0.81 to 1.73) in older. p-value was
significant; p = 0.0201.
Discussion
In the present analysis, we evaluated the association be-
tween categories of sleep duration and snoring frequency
as well as the duration of activity with AMI risk factors
and to the risk of developing an AMI.
We observed an inverse association between serious
snoring frequency and AMI risk after controlling for
similar demographic and potential confounders. People
having serious snoring increased 77% risk of AMI. Our
results found that there was an increased risk for CVD
in China population who slept less than 6 hours or more
than 8 hours per day when compared with those who
sleep 6 to 8 hours per day. Another study found that the
odds of sleeping less than 6 hours per night was lower
for women and married persons [14]. The Nurse’s Health
Study found a modest relationship between coronary






1.40 (1.18-1.68) 1.43 (1.14-1.79)
1.00 1.00
1.79 (1.49-2.14) 1.80 (1.48-2.18)
2.53 (1.82-3.51) 2.51 (1.75-3.58)
1.84 (1.47-2.30) 1.52 (1.17-1.97)
1.03 (0.63-1.70) 0.88 (0.50-1.52)
1.80 (1.05-3.09) 0.83 (0.46-1.50)
1.05 (0.56-1.97) 1.13 (0.57-2.24)
1.89 (1.58-2.27) 1.88 (1.51-2.34)
1.66 (1.27-2.17) 1.30 (0.97-1.76)
0.96 (0.77-1.19) 1.10 (0.86-1.39)
0.58 (0.42-0.78) 0.57 (0.40-0.81)
1.00 1.00
2.13 (1.73-2.63) 1.89 (1.49-2.38)
2.31 (1.83-2.90) 2.16 (1.67-2.79)
0.83 (0.63-1.11) 0.92 (0.68-1.26)
Table 5 Interaction between snoring frequency and other related factors of AMI
No snoring 0-1 time per week 1-3 times per week >3 times P-value for interaction
Age (years), mean (SD) 0.0133
Case 62.5 (12.4) 61.8 (11.1) 62.5 (11.7) 60.9 (11.4)
Control 59.5 (12.7) 59.9 (10.5) 61.0 (11.4) 60.5 (11.0)
BMI (kg/m2), mean (SD) 0.7755
Case 24.0 (3.4) 24.5 (3.4) 24.8 (3.1) 25.6 (3.3)
Control 23.6 (3.0) 24.7 (2.7) 24.6 (2.8) 25.3 (3.9)
WHR, mean (SD) 0.0179
Case 0.87 (0.08) 0.89 (0.07) 0.86 (0.09) 0.91 (0.08)
Control 0.88 (0.08) 0.89 (0.08) 0.86 (0.09) 0.90 (0.07)
Hypertension, n (%) 0.2176
Case 190 (34.8) 198 (31.2) 450 (40.4) 289 (53.3)
Control 111 (15.3) 153 (19.2) 286 (26.8) 105 (33.6)
Diabetes, n (%) 0.8630
Case 58 (10.6) 63 (9.9) 153 (13.7) 76 (14.0)
Control 21 (2.9) 18 (2.3) 35 (3.3) 12 (3.8)
Stroke, n (%) 0.2193
Case 42 (7.7) 54 (8.5) 155 (13.9) 63 (11.7)
Control 16 (2.2) 19 (2.4) 47 (4.4) 19 (6.1)
Current smokers, n (%) 0.1616
Case 242 (44.3) 356 (56.1) 655 (58.7) 404 (74.5)
Control 214 (29.5) 325 (40.8) 462 (43.2) 176 (56.2)
Alcohol consumption (≥1/week), n (%) 0.8611
Case 50 (9.2) 85 (13.4) 198 (17.8) 121 (22.3)
Control 74 (10.2) 82 (10.3) 186 (17.4) 78 (24.9)
Physical activity, n (%) 0.7550
Case 93 (17.0) 65 (10.3) 122 (11.0) 132 (24.4)
Control 137 (18.9) 117 (14.7) 196 (18.3) 84 (27.0)
Education (≤8 years), n (%) 0.5209
Case 292 (53.5) 340 (53.6) 631 (56.6) 253 (46.7)
Control 308 (42.5) 343 (43.3) 520 (48.6) 114 (36.4)
Low family income, n (%) 0.8004
Case 188 (34.6) 200 (31.6) 323 (31.7) 175 (32.4)
Control 221 (30.7) 242 (30.4) 321 (30.1) 76 (24.3)
Permanent stress, n (%) 0.0148
Case 199 (36.5) 262 (41.3) 399 (35.8) 193 (35.7)
Control 194 (26.8) 263 (33.0) 369 (34.6) 101 (32.3)
Depression, n (%) 0.5744
Case 113 (21.3) 118 (18.9) 179 (16.2) 127 (23.8)
Control 75 (10.5) 70 (8.9) 77 (7.3) 45 (14.4)
Vegetables consumption, (times/week), mean (SD) 0.0001
Case 7.1 (5.3) 6.6 (5.0) 8.2 (5.5) 9.3 (6.0)
Control 7.7 (5.5) 7.5 (4.9) 8.3 (5.4) 8.4 (5.8)
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Table 5 Interaction between snoring frequency and other related factors of AMI (Continued)
Fruit consumption, (times/week), mean (SD) 0.0270
Case 3.5 (3.5) 3.5 (3.2) 4.5 (3.5) 4.2 (4.4)
Control 4.4 (4.0) 4.5 (3.3) 5.3 (3.5) 4.6 (3.8)
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less than 6 hours of sleep was associated with a significant
2-fold increase in CVD events in men and a non signifi-
cant trend in women [4]. Our data are consistent with
those of the National Health Interview Survey that
showed that sleep duration was a significant predictor of
CVD independent of age, gender, and race/ethnicity [2].
Lack of sleep has been linked to several CVD traditional
and psychosocial risk factors, as observed in our study.
Previous research has shown that sleep deprivation results
in decreased glucose tolerance and elevated blood pres-
sure [2].
In the present prospective study, snoring frequency
was associated with an increased incidence of cardiovas-
cular events among community-dwelling middle-aged
Japanese women. This association was independent of
age and other confounding factors. As compared with
never snorers, ‘everyday snoring’ women had a 2.5-fold
higher risk of cardiovascular events during 6 years of
follow-up. The association of everyday snoring with
cardiovascular events was attenuated after adjustment
for BMI and after further adjustment for systolic bloodFigure 1 Adjusted odds ratios (and 95% confidence intervals), with te
snore frequency by different type of gender and age.pressure, antihypertensive medication use, diabetes mellitus,
and hypercholesterolemia. This suggested that overweight
partly mediated the association and that hypertension and
metabolic abnormalities partly caused by snoring contribute
to the risk of cardiovascular events in women who snore
every day. This is the first study to show a relationship be-
tween habitual snoring and risk of cardiovascular events
among a population in Asia, which has a low prevalence
of obesity. The biological mechanisms that link habitual
snoring to the development of cardiovascular disease re-
main to be fully elucidated, but a number of mechanisms
have been proposed. Habitual snoring is often accompan-
ied by sleep apnea or hypopnea. Repetitive episodes of
intermittent complete and partial airway collapse during
sleep result in hypoxemia, hypercapnia, changes in intra-
thoracic pressure, and repeated arousal from sleep. Epi-
sodes of snoring and apneic events can cause acute
hemodynamic changes (such as increased cardiac output,
enhanced cardiac arrhythmia, patent foramen ovale ap-
pearance, increased intracranial pressure, and decreased
cerebral blood flow) [25], increased platelet aggregation
and fibrinogen concentrations [26,27], and decreasedsts for heterogeneity for risk of acute myocardial infarction for
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tem. Abnormal metabolic conditions such as hyperten-
sion, diabetes mellitus, and hypercholesterolemia may also
increase the risk of cardiovascular disease via elevation of
sympathetic activation, oxidative stress [28-30], activation
of the hypothalamic-pituitary-adrenal axis due to sleep
fragmentation, and endothelial dysfunction [31-33].
In our study, we observed snoring frequency was more
significant associated with AMI in men, compared to
women in China population. In contrast to the signifi-
cant association of habitual snoring with cardiovascular
events in women, no such association was observed in
men. Large population-based prospective studies of middle-
aged men, women, and a population of men and women
aged 20 years or older have reported positive associations
between habitual snoring and cardiovascular events [21,22].
However, no study has reported a sex difference in the asso-
ciation. Recent reports from the Sleep Heart Health Study
(a large population-based study of American residents
aged 40 or older) have noted sex differences in the associ-
ation between SDB, as defined by the apnea-hypopnea
index (AHI), and the risk of coronary heart disease, heart
failure, and stroke [34,35]. The multivariable HRs associ-
ated with a 10-unit increase in AHI were 1.1 (1.0-1.3) for
incident heart failure in men and 1.1 (1.0-1.2) for incident
coronary heart disease in men aged 70 years or younger,
whereas no such associations were observed in women
[21]. Similarly, the multivariable HR for ischemic stroke
incidence was 2.9 (1.1-7.4) in men and 1.2 (0.7-2.2) in
women for the highest (>19) as compared with the lowest
(≤4) AHI quartiles [22]. The reasons for the present lack
of association between habitual snoring and risk of cardio-
vascular events in men are unknown. We found stronger
association in men than women when the analysis was
stratified by age, smoking, or drinking status. Further re-
search is necessary to elucidate this sex difference.
Several limitations of this study should be considered.
First, a large potential disadvantage was that this control
population may not be representative of the general
Chinese population, nor were the AMI cases representa-
tive of all Chinese AMI patients. And all the individuals
were drawn from urban communities, so the study results
may not necessarily apply to rural regions. Other potential
sources of bias in our investigation include the selection
of controls and a differential recall among cases compared
with control subjects. While the use of population based
controls would be ideal, we addressed selection bias that
may arise with use of hospital-based controls by obtaining
control subjects from other different outpatient clinics
and inpatient wards in the hospital. Therefore, if an asso-
ciation exists between the exposure of interest and the dis-
ease status of one control group, the bias that may result
would be diluted. Additionally, we used a systematic
method of control selection that would avoid arbitraryselection of controls within wards and clinics. Differential
recall of sleep duration and snoring frequency is also a po-
tential concern; however, research assistants asked case
subjects to specifically report on their level of sleep dur-
ation and snoring frequency prior to their myocardial in-
farction. While the potential for recall bias may exist,
awareness of heart disease prevention and health con-
sciousness may not be as high among our study popula-
tion in China as its is in Western countries; hence the
likelihood of recall bias may be lower. We also excluded
all those with any prior heart disease from the study. As
well, while we cannot exclude the possibility that not all
sleep and snoring condition was reported, interviewers
were trained to conduct thorough interviews on sleep and
snoring during the day or night. While future prospective
research within China will adequately address these biases,
the case–control design had the advantage of being cost,
resource, and time efficient.
In the further research, we need to determine the
mechanisms of this association exactly. New study de-
signs and methods need to be developed. Testing the
theoretical models of potential mechanisms is highly
dependent on the quality of study design and the data
that results. One serious problem with the existing stud-
ies is retrospective. New epidemiological methods have
been developed to overcome or evaluate some existing
problems. The prospective research about the impact of
physical activities on health outcomes at different eco-
nomic development levels is currently being studied in
the Prospective Urban Rural Epidemiologic study (PURE
study) [36-38]. Further, there may be heterogeneity be-
tween physical activities and health outcomes across dif-
ferent populations through 20 years follow-up. In PURE
study, more fine measures of physical activities during
the life course are needed.
Conclusions
Snoring frequency, including as much as everyday and
3–5 times per week, was positively associated with AMI
risk and less sleep duration was associated with risk of
AMI. Less sleep time could increase AMI risk in China
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